Vivek Jayaraman

Vivek Jayaraman serves as Chief Operating Officer at Cerus. Cerus operates in the research sector with approximately 380.0 employees. The company is headquartered in Healdsburg, California. Cerus generates annual revenue of 180300000.0.

Industry & Role Insights

• • MessageCEO tracks 2,961 executives in the research sector.
• • 13,743 executive contacts are available in California.
• • Our database includes 201,469 c suite-level executives.

Outlook Microsoft Office 365 Google Cloud Hosting Hubspot WP Engine Greenhouse.io Mobile Friendly Google Font API Vimeo WordPress.org Nginx Google Tag Manager Google Analytics Remote AI

blood safety pathogen inactivation hospital safety patient safety pandemic preparedness plasma pathogen reduction blood supply healthcare public health transfusion medicine platelets bleeding edp services technology biotechnology research intercept blood system platelet products plasma safety cryoprecipitation technology blood supply integrity fda approval ce mark blood centers hospital blood banks safe blood for patients clinical education investor relations annual reports financial transparency regulatory compliance quality assurance blood component technology global health patient care customer collaboration medical devices transfusion practices biotechnology clinical development manufacturing operations life sciences biopharmaceuticals innovation in healthcare healthcare partnerships health & safety therapeutic solutions community health employee commitment diversity & inclusion sustainability in healthcare social responsibility transfusion-transmitted infections supply chain efficiency scientific research hemorrhage treatment fibrinogen deficiency blood product development clinical trials blood safety standards medical innovation emerging pathogens biomedical blood components cryoprecipitated fibrinogen hospitals operational efficiency innovative technologies global standard of care healthcare providers scientific rigor collaboration blood transfusion safety clinical outcomes resource efficiency blood product availability international blood safety customer-centric approach healthcare innovation transfusion therapies health care health wellness & fitness hospital & health care

SN

Srikanth Nandiraju Chief Technology Officer at 1Cell.Ai Inc.

SD

Surinnder Dang Chief Business Officer at 1Cell.Ai Inc.

M

Mark Chief Executive Officer at 23Strands

IT

Ilia Tikhomirov Chief Executive Officer at 35Pharma

AD

Alistair Draffan Chief Executive Officer at 360biolabs Pty Ltd

Outreach Guidance — research Sector

Executives like Vivek Jayaraman in the research sector receive targeted outreach from sales teams, recruiters, and investors. To stand out, personalize your message with industry-specific context and a clear, specific value proposition relevant to their role at Cerus.

How do I reach Vivek Jayaraman directly?

Vivek Jayaraman's verified email address is available to MessageCEO Pro subscribers. They currently serve as Chief Operating Officer at Cerus. Access direct contact info to skip gatekeepers and reach the decision maker.

What company does Vivek Jayaraman work for?

Vivek Jayaraman is Chief Operating Officer at Cerus, a company in the research sector with 380.0 employees. The company is based in Healdsburg, California.

Can I pitch or sell to Vivek Jayaraman?

As Chief Operating Officer at Cerus, Vivek Jayaraman is a key decision-maker in the research sector. MessageCEO Pro gives you verified email to reach Vivek Jayaraman directly — ideal for B2B sales, partnerships, and executive recruiting.

What industry is Vivek Jayaraman in?

Vivek Jayaraman works in the research industry as Chief Operating Officer at Cerus. MessageCEO provides verified contact information for executives across all major industries.

Is Vivek Jayaraman's contact information verified?

Yes. MessageCEO verifies executive contact information through multiple data sources and regular validation checks. Vivek Jayaraman's profile is kept up-to-date with the latest available information.

Last updated: May 12, 2026